Trichomegaly Due to Panitumumab.
作者信息
Taboada Paz Laura, Vicente Basanta Elena, Monteagudo Sánchez Benigno
机构信息
Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
出版信息
JAMA Dermatol. 2024 Jun 1;160(6):667. doi: 10.1001/jamadermatol.2024.0642.
Abstract
摘要
相似文献
1
Trichomegaly Due to Panitumumab.
JAMA Dermatol. 2024 Jun 1;160(6):667. doi: 10.1001/jamadermatol.2024.0642.
2
Panitumumab-induced trichomegaly.
Curr Probl Cancer. 2021 Dec;45(6):100748. doi: 10.1016/j.currproblcancer.2021.100748. Epub 2021 Apr 23.
3
Trichomegaly Associated with Panitumumab.
N Engl J Med. 2020 Oct 15;383(16):e94. doi: 10.1056/NEJMicm2003622.
4
Hypertrichosis of the pinnae in a patient using panitumumab.
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e277-e278. doi: 10.1111/jdv.14815. Epub 2018 Feb 15.
5
Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment.
J Cancer Res Ther. 2020 Apr-Jun;16(3):690-692. doi: 10.4103/jcrt.JCRT_343_17.
6
Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer.
BMJ Case Rep. 2019 Apr 30;12(4):e228968. doi: 10.1136/bcr-2018-228968.
7
Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.
World J Gastroenterol. 2019 Aug 7;25(29):4007-4018. doi: 10.3748/wjg.v25.i29.4007.
8
Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With Panitumumab.
Clin J Oncol Nurs. 2019 Apr 1;23(2):157-164. doi: 10.1188/19.CJON.157-164.
9
A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome.
BMJ Case Rep. 2019 Feb 9;12(2):e227785. doi: 10.1136/bcr-2018-227785.
10
Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease.
Cancer Chemother Pharmacol. 2018 Jan;81(1):179-182. doi: 10.1007/s00280-017-3479-2. Epub 2017 Nov 23.
Zotero 插件